All animals used for the cell cultures were maintained and treated
in accordance with the ARVO Statement for the Use of Animals in
Ophthalmic and Vision Research. Newborn Lewis rats, 5 to 7 days of age,
were obtained from Charles River (Wilmington, MA). The eyes were
enucleated and hemisected, and the lens and vitreous were removed. The
retina was carefully removed, taking care to avoid pigment epithelium
contamination, and placed in Dulbecco’s modified Eagle’s medium
(DMEM; Gibco, Grand Island, NY), containing 10% fetal bovine serum
(FBS; Atlanta Biologicals, Norcross, GA) and 1%
penicillin-streptomycin (Gibco). Retinas were digested with 0.05%
trypsin in 0.53 mM EDTA (Gibco) for 1 hour at 37°C. After DMEM with
10% FBS (DMEM-FBS) was added to terminate trypsinization, the retinal
pieces were dissociated by trituration and centrifuged. The retinal
cells were cultured in DMEM-FBS supplemented with either 5 ng/ml human
M-CSF (Sigma, St. Louis, MO) or 1 ng/ml murine granulocyte–macrophage
(GM)-CSF (Sigma). Retinas were allowed to grow in
75-cm2 flasks for at least 3 days and then were
replenished with additional medium. For purification, after washing,
the cells were incubated with
Ca2+-Mg2+–free Hanks’
balanced salt solution (HBSS; Sigma) containing 0.2% EDTA and 5% FBS
for 1 hour at 4°C and detached by vigorous pipetting. The resultant
cell suspension was placed in plastic flasks and allowed to adhere for
30 minutes at 37°C. Afterward, loosely adhering and suspended cells
were removed by gently shaking the flasks at room temperature. Cultures
were maintained in a humidified atmosphere of 95% air-5%
CO2 at 37°C. The average density of the
microglial cells was 3 × 106 cells/flask
and 7.5 × 106 cells/flask for cells grown
in M-CSF and GM-CSF, respectively.
For fluorescence-activated cell sorter (FACS) analysis, microglial
cells were cultured in M-CSF for 7 days, after which the cells were
incubated with 100u/ml IFN-γ for 24 hours.